Evaluation of biological activity of quantum dots in a microsystem

Quantum Dots: An Emerging Tool for Point-of-Care Testing

Quantum dots (QDs) are semiconductor crystals in the nanodimension having unique optical and electronic properties that differ from bulk material due to quantum mechanics. The QDs have a narrow emission peak, size-dependent emission wavelength, and broad excitation range which can be utilized for diverse biomedical applications such as molecular imaging, biosensing, and diagnostic systems. This article reviews the current developments of biomedical applications of QDs with special reference to point-of-care testing.

Luminescence enhancement of alloyed quantum dots bound to gold nanoparticles by mercaptocarboxylic acids in colloidal complexes

The understanding of the physical mechanisms of the nanoobjects interaction within the nanostructured complex materials is one of the main tasks for the development of novel materials with tunable properties. In this work, we develop a formation procedure of the colloidal complexes based on alloyed CdZnSe/ZnS quantum dots and gold nanoparticles where the various mercaptocarboxylic acids are used as the binding molecules. The QD photoluminescence enhancement (up to ×3.1) can be achieved by the control of the interparticle distance in colloidal solutions. We provide a detailed discussion on the influence of the linking molecules on the nanoparticle complexes optical parameters through the steady-state and time-resolved spectral measurements.

A sensitive and versatile method for characterization of protein-mediated transformations of quantum dots

We report the development and application of an analytical system consisting of capillary electrophoresis (CE) interfaced with inductively coupled plasma mass spectrometry (ICP-MS) for sensitive and high-resolution characterization of quantum dots (QDs) interacting with serum proteins. Separation resolution between the intact CdSeS/ZnS QDs and their protein conjugates was optimized by varying the type and concentration of background electrolyte, applied voltage, and sample loading. Special attention was paid to the CE system compatibility with physiological conditions, avoiding aggregation effects, and analyte recovery. Optimization trials allowed for acquiring satisfactory stability of migration times (within 6.0% between different days), peak area precision of 5.2-8.0%, capillary recoveries in the range of 90-96%, and a lower limit of detection of 7.5 × 10(-9) mol L(-1) Cd. With the developed method distinct metal-specific profiles were obtained for the QDs in combination with individual serum proteins, their mixtures, and in human serum. Particularly, it was found that albumin binding to the particle surface is completed after 1 h, without noticeable disruption of the core-shell integrity. The transferrin adsorption is accompanied by the removal of the ZnS shell, resulting in evolving two different metal-protein conjugated forms. On the other hand, proteinization in real-serum environment occurs without binding to major transport proteins, the QDs also lose their the shell (the higher the dose the longer is the time they stay unbroken). The concomitant changes in migration behavior can be attributed to interactions with serum proteins other than albumin and transferrin. Speciation information provided by CE-ICP-MS may shed light on the mechanism of QD delivery to the target regions of the body.